Cargando…
Hereditary Breast Cancer: Clinical, Pathological and Molecular Characteristics
Pathogenic mutations in BRCA1 or BRCA2 are only detected in 25% of families with a strong history of breast cancer, though hereditary factors are expected to be involved in the remaining families with no recognized mutation. Molecular characterization is expected to provide new insight into the tumo...
Autores principales: | Larsen, Martin J, Thomassen, Mads, Gerdes, Anne-Marie, Kruse, Torben A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213954/ https://www.ncbi.nlm.nih.gov/pubmed/25368521 http://dx.doi.org/10.4137/BCBCR.S18715 |
Ejemplares similares
-
RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families
por: Larsen, Martin J, et al.
Publicado: (2014) -
Microarray-Based RNA Profiling of Breast Cancer: Batch Effect Removal Improves Cross-Platform Consistency
por: Larsen, Martin J., et al.
Publicado: (2014) -
The Pathology of Hereditary Breast Cancer
por: Honrado, Emiliano, et al.
Publicado: (2004) -
Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
por: Larsen, Martin J., et al.
Publicado: (2013) -
Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer
por: Thomassen, Mads, et al.
Publicado: (2008)